Literature DB >> 33436497

Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.

Bálint Mészáros1, Hugo Sámano-Sánchez2, Jesús Alvarado-Valverde2,3, Jelena Čalyševa2,3, Elizabeth Martínez-Pérez2,4, Renato Alves2, Denis C Shields5, Manjeet Kumar1, Friedrich Rippmann6, Lucía B Chemes7, Toby J Gibson1.   

Abstract

The first reported receptor for SARS-CoV-2 on host cells was the angiotensin-converting enzyme 2 (ACE2). However, the viral spike protein also has an RGD motif, suggesting that cell surface integrins may be co-receptors. We examined the sequences of ACE2 and integrins with the Eukaryotic Linear Motif (ELM) resource and identified candidate short linear motifs (SLiMs) in their short, unstructured, cytosolic tails with potential roles in endocytosis, membrane dynamics, autophagy, cytoskeleton, and cell signaling. These SLiM candidates are highly conserved in vertebrates and may interact with the μ2 subunit of the endocytosis-associated AP2 adaptor complex, as well as with various protein domains (namely, I-BAR, LC3, PDZ, PTB, and SH2) found in human signaling and regulatory proteins. Several motifs overlap in the tail sequences, suggesting that they may act as molecular switches, such as in response to tyrosine phosphorylation status. Candidate LC3-interacting region (LIR) motifs are present in the tails of integrin β3 and ACE2, suggesting that these proteins could directly recruit autophagy components. Our findings identify several molecular links and testable hypotheses that could uncover mechanisms of SARS-CoV-2 attachment, entry, and replication against which it may be possible to develop host-directed therapies that dampen viral infection and disease progression. Several of these SLiMs have now been validated to mediate the predicted peptide interactions.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2021        PMID: 33436497     DOI: 10.1126/scisignal.abd0334

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  22 in total

Review 1.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

Review 2.  The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.

Authors:  Peter J Richardson; Bruce W S Robinson; Daniel P Smith; Justin Stebbing
Journal:  Vaccines (Basel)       Date:  2022-06-15

3.  Receptor binding domain of SARS-CoV-2 is a functional αv-integrin agonist.

Authors:  Emma G Norris; Xuan Sabrina Pan; Denise C Hocking
Journal:  bioRxiv       Date:  2022-04-11

Review 4.  The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies.

Authors:  Vaishali P Waman; Neeladri Sen; Mihaly Varadi; Antoine Daina; Shoshana J Wodak; Vincent Zoete; Sameer Velankar; Christine Orengo
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

5.  Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.

Authors:  Aleksandra Gruca; Joanna Ziemska-Legiecka; Patryk Jarnot; Elzbieta Sarnowska; Tomasz J Sarnowski; Marcin Grynberg
Journal:  BMC Bioinformatics       Date:  2021-04-08       Impact factor: 3.169

6.  Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE.

Authors:  Su Datt Lam; Paul Ashford; Sandra Díaz-Sánchez; Margarita Villar; Christian Gortázar; José de la Fuente; Christine Orengo
Journal:  Viruses       Date:  2021-04-19       Impact factor: 5.048

7.  The Eukaryotic Linear Motif resource: 2022 release.

Authors:  Manjeet Kumar; Sushama Michael; Jesús Alvarado-Valverde; Bálint Mészáros; Hugo Sámano-Sánchez; András Zeke; Laszlo Dobson; Tamas Lazar; Mihkel Örd; Anurag Nagpal; Nazanin Farahi; Melanie Käser; Ramya Kraleti; Norman E Davey; Rita Pancsa; Lucía B Chemes; Toby J Gibson
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 8.  Dynamic, but Not Necessarily Disordered, Human-Virus Interactions Mediated through SLiMs in Viral Proteins.

Authors:  Heidy Elkhaligy; Christian A Balbin; Jessica L Gonzalez; Teresa Liberatore; Jessica Siltberg-Liberles
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

9.  SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.

Authors:  Bo Yang; Yuanyuan Jia; Yumin Meng; Ying Xue; Kefang Liu; Yan Li; Shichao Liu; Xiaoxiong Li; Kaige Cui; Lina Shang; Tianyou Cheng; Zhichao Zhang; Yingxiang Hou; Xiaozhu Yang; Hong Yan; Liqiang Duan; Zhou Tong; Changxin Wu; Zhida Liu; Shan Gao; Shu Zhuo; Weijin Huang; George Fu Gao; Jianxun Qi; Guijun Shang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205

Review 10.  Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.

Authors:  Dermot Cox
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.